Drug Shortage Report for APO-ELETRIPTAN

Last updated on 2020-01-07 History
Report ID 308
Drug Identification Number 02386062
Brand name APO-ELETRIPTAN
Common or Proper name ELETRIPTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ELETRIPTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01
Estimated end date 2020-01-10
Actual end date 2019-12-31
Shortage status Resolved
Updated date 2020-01-07
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-01-07 French Compare
v11 2020-01-07 English Compare
v10 2019-12-13 French Compare
v9 2019-12-13 English Compare
v8 2019-10-07 French Compare
v7 2019-10-07 English Compare
v6 2017-09-29 French Compare
v5 2017-09-29 English Compare
v4 2017-06-19 French Compare
v3 2017-06-19 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare